Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500115343Phase 4Not yet recruiting
Phase 4, randomised trial of fospropofol disodium (2 arms), sponsored by Jiaxing Second Hospital. Primary endpoints: success rate of sedation and onset time of sedation effect. Planned start Dec 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500115343.